InvestorsHub Logo
Followers 118
Posts 1968
Boards Moderated 0
Alias Born 11/22/2017

Re: flipper44 post# 231423

Tuesday, 06/04/2019 9:06:44 PM

Tuesday, June 04, 2019 9:06:44 PM

Post# of 731909

Your logic is sound, but, for instance, the info arm does not match up with blended phase three at three years.



Flipper44,

Look at slide 33: https://nwbio.com/wp-content/uploads/ASCO-2019-Presentation-FINAL.pdf

7 patients lived for 3 years or more.
3 patients died between 35 and 36 months.

7/25= 28%

IMO 28% (from the 25 Information Arm patients) appear consistent with the blinded interim data from the trial.

SNO data 2018:
Survival of the whole ITT population at 3 years: 28.2%

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News